Gross Profit: Revenues from operations less the associated costs.
Novartis AG (NVS) had Gross Profit of $42.98B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$56.67B |
|
$13.98B |
|
$13.70B |
|
|
Gross Profit |
$42.98B |
$39.03B |
|
$17.64B |
|
$-1.29B |
|
$16.35B |
|
$16.35B |
|
$13.97B |
|
$13.97B |
|
$13.97B |
|
$13.97B |
|
$17.64B |
|
$22.92B |
|
1.94B |
|
1.96B |
|
$7.21 |
|
$7.15 |
|
| Balance Sheet Financials | |
$30.46B |
|
$10.78B |
|
$80.49B |
|
$110.95B |
|
$27.28B |
|
$27.93B |
|
$37.12B |
|
$64.40B |
|
$46.55B |
|
$-8.43B |
|
$46.55B |
|
1.91B |
|
| Cash Flow Statement Financials | |
$19.14B |
|
$-4.88B |
|
$-14.87B |
|
$11.46B |
|
$11.44B |
|
$-24.00M |
|
$1.10B |
|
$-7.82B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
0.38 |
|
0.72 |
|
75.83% |
|
31.13% |
|
31.13% |
|
40.44% |
|
28.85% |
|
24.67% |
|
$17.61B |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
2.19 |
|
6.20 |
|
58.88 |
|
30.00% |
|
-165.70% |
|
12.59% |
|
18.75% |
|
$24.39 |
|
$9.01 |
|
$9.79 |
|